Lucis
Category: AI in Healthcare
AI-powered preventive health platform that turns routine blood, urine and saliva tests into personalized, actionable longevity insights — 'Function Health for Europe'. Lucis was founded in 2025. The company is led by Max Berthelot. Based in Paris, France. Team size: 11-50. Total funding raised: $28.5M. Latest round: Series A. Key investors include Singular (Series A lead), General Catalyst, Y Combinator.
- Founded
- 2025
- Headquarters
- Paris, France
- Team size
- 11-50
- Total funding
- $28.5M
Value proposition
Combines medical expertise and AI to transform regular biomarker testing (110+ data points across 11 body systems) into a personalized action plan for nutrition, sleep, and movement, at a fraction of the cost of private longevity clinics.
Products and solutions
Lucis Care membership (2 full biological check-ups/year, 100+ biomarkers, AI-driven dashboard, personalized action plans), longevity add-on tests (microbiome, continuous glucose monitoring, food sensitivity), wearable integrations (Garmin, Withings, Strava, Oura, Apple Watch/Whoop coming soon).
Unique value
AI health navigator combining lab biomarkers + wearable data + personalized coaching into a single longitudinal health companion, delivered via a large partner-lab network (450+ across Europe) rather than building lab infrastructure in-house.
Target customer
Health-conscious consumers (18+) in Europe interested in longevity, preventive care and biomarker tracking; also B2B via 'Lucis for Startups' employee health benefit.
Industries served
Preventive healthcare, longevity, digital health, consumer health-tech
Technology advantage
AI layer that synthesizes biomarker + wearable + questionnaire data into personalized, continuously updated health protocols; asset-light partner-lab network model (Eurofins and others) enabling rapid European geographic scaling; HDS/ISO27001/GDPR-compliant data infrastructure.
How they differentiate
Purpose-built for the European market (regulatory compliance, local lab network across France/UK/Ireland/Portugal) versus US-first competitors like Function Health and Superpower; positions as an 'AI health navigator' extending beyond one-off testing into continuous personalized coaching.
Main competitors
Function Health (US), Superpower (US), InsideTracker (US), ZOE (UK), Mito Health, Ahead Health (Swiss)
Key partnerships
450+ partner labs across Europe including Eurofins network, Randox (UK diagnostic lab network), wearable integrations with Garmin, Withings, Strava, Oura
Notable customers
10+ AI startups gifting Lucis as an employee health benefit (per YC launch post), individual consumer members (10,000+)
Major milestones
YC Spring 2025 batch, beta launch in Paris (2025), expansion to Lisbon and London, €7.2M/$8.5M Seed round (Dec 2025), $20M Series A led by Singular (May 2026), planned expansion into Spain, Germany, Italy by end of 2026.
Growth metrics
10,000+ members, rated 4.5/5 on Trustpilot, 1,000,000+ analyses run, 450+ partner labs across Europe; at Seed stage had 30,000+ community members and 500+ Paris users in first 4 months.
Market positioning
Consumer longevity/preventive-health platform positioned as the accessible European alternative to expensive private longevity clinics (€50K+/year), priced at ~€490/year membership.
Geographic focus
Europe (France, UK, Ireland, Portugal live; expanding to Spain, Germany, Italy by end of 2026), competing globally with US-based biomarker platforms.
About Max Berthelot
15+ years building consumer internet businesses; founded and sold PixelMe (SaaS); founded/scaled profitable D2C health & supplement businesses; built and operated one of Europe's largest longevity media/community platforms (seeded Lucis early traction). Prior growth/product roles including Buffer. Le Wagon full-stack (2020).
Latest news about Lucis
More AI in Healthcare companies
Official website: https://www.lucis.life